drugset / Trial / NCT06574100
Relative Bioavailability of Two Orally Administered CBD Formulations in Healthy Male Adults
RandomizedCrossoverOpen-labelBasic science
Summary
This project is aimed at understanding whether a new fast-dissolving cheek-administered cannabidiol strip will be absorbed better into the body than cannabidiol powder. The results of this study will help guide dosage formulation choices as well as dosing regimens in NFL athletes for concussion management.
Timeline
- Start
- 2024-10-26
- Primary completion
- 2025-11
- Completion
- 2025-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cannabidiol | Other / unclassified | 250 mg | Other |
| Comparator | Cannabidiol | Other / unclassified | 1000 mg | Other |
| Comparator | Cannabidiol | Other / unclassified | 3000 mg | Other |
Indications
No indication recorded.